SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

SECTION 1. IDENTIFICATION
Product name:Rizatriptan Orally Disintegrating Formulation

Manufacturer or supplier's details
Company name of supplier: Organon & Co.
Address: 30 Hudson Street, 33nd floor
Jersey City, New Jersey, U.S.A 07302
Telephone: 1-551-430-6000
Emergency telephone: 1-215-631-6999
E-mail address: EHSSTEWARD@organon.com
Recommended use of the chemical and restrictions on use
Recommended use: Pharmaceutical
Restrictions on use: Not applicable
SECTION 2. HAZARDS IDENTIFICATIONGHS classification in accordance with the OSHA Hazard Communication Standard (29 CFR
1910.1200)
Combustible dust
Skin sensitization:

Category 1

Reproductive toxicity:

Category 2

Specific target organ toxicity- repeated exposure (Oral):

Category 1 (Cardio-vascular system)

GHS label elements
Hazard pictograms:

Signal Word:

DangerHazard Statements:

If small particles are generated during further processing, handling or by other means, may form combustible dust concentrations in air.
H317 May cause an allergic skin reaction.
H361d Suspected of damaging the unborn child.
H372 Causes damage to organs (Cardio-vascular system)
through prolonged or repeated exposure if swallowed.

Precautionary Statements:

Prevention:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been readand understood.
P260 Do not breathe dust.
1 / 20SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

P264 Wash skin thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P272 Contaminated work clothing must not be allowed out of
the workplace.
P280 Wear protective gloves, protective clothing, eye protection
and face protection.
Response:
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
P308 + P313 IF exposed or concerned: Get medical attention.
P333 + P313 If skin irritation or rash occurs: Get medical attention.
P363 Wash contaminated clothing before reuse.
Storage:
P405 Store locked up.
Disposal:
P501 Dispose of contents and container to an approved waste
disposal plant.
Other hazards
Dust contact with the eyes can lead to mechanical irritation.
SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance / Mixture:

MixtureComponents
Chemical name
CAS-No.
Cellulose
9004-34-6
Aspartame
22839-47-0
Peppermint oil
8006-90-4
Starch
9005-25-8
Rizatriptan
145202-66-0
Actual concentration is withheld as a trade secretConcentration (% w/w)>= 10 - < 20>= 5 - < 10>= 1 - < 5>= 1 - < 5>= 1 - < 5

SECTION 4. FIRST AID MEASURES
General advice:

If inhaled:

In case of skin contact:

In case of eye contact:

If swallowed:

In the case of accident or if you feel unwell, seek medical
advice immediately.
When symptoms persist or in all cases of doubt seek medical
advice.
If inhaled, remove to fresh air.
Get medical attention.
In case of contact, immediately flush skin with plenty of water.
Remove contaminated clothing and shoes.
Get medical attention.
Wash clothing before reuse.
Thoroughly clean shoes before reuse.
If in eyes, rinse well with water.
Get medical attention if irritation develops and persists.
If swallowed, DO NOT induce vomiting.
2 / 20SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Most important symptoms
and effects, both acute anddelayed:Protection of first-aiders:

Notes to physician:

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

Get medical attention.
Rinse mouth thoroughly with water.
May cause an allergic skin reaction.
Suspected of damaging the unborn child.
Causes damage to organs through prolonged or repeatedexposure if swallowed.
Dust contact with the eyes can lead to mechanical irritation.
First Aid responders should pay attention to self-protection,and use the recommended personal protective equipment
when the potential for exposure exists (see section 8).
Treat symptomatically and supportively.

SECTION 5. FIRE-FIGHTING MEASURES
Suitable extinguishing media:

Water spray
Alcohol-resistant foam
Carbon dioxide (CO2)
Dry chemical
None known.

Unsuitable extinguishingmedia
Specific hazards during firefighting::

Avoid generating dust; fine dust dispersed in air in sufficientconcentrations, and in the presence of an ignition source is apotential dust explosion hazard.
Exposure to combustion products may be a hazard to health.

Hazardous combustion products:

Carbon oxides
Nitrogen oxides (NOx)Specific extinguishing methods:

Special protective equipment
for fire-fighters:

Use extinguishing measures that are appropriate to local circumstances and the surrounding environment.
Use water spray to cool unopened containers.
Remove undamaged containers from fire area if it is safe to doso.
Evacuate area.
In the event of fire, wear self-contained breathing apparatus.
Use personal protective equipment.

SECTION 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protec- :tive equipment and emergency procedures

Use personal protective equipment.
Follow safe handling advice (see section 7) and personal
protective equipment recommendations (see section 8).

Environmental precautions:

Avoid release to the environment.
Prevent further leakage or spillage if safe to do so.
Retain and dispose of contaminated wash water.
Local authorities should be advised if significant spillages
cannot be contained.

Methods and materials forcontainment and cleaning up:

Sweep up or vacuum up spillage and collect in suitablecontainer for disposal.
Avoid dispersal of dust in the air (i.e., clearing dust surfaces
with compressed air).
3 / 20SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

Dust deposits should not be allowed to accumulate on
surfaces, as these may form an explosive mixture if they are
released into the atmosphere in sufficient concentration.
Local or national regulations may apply to releases anddisposal of this material, as well as those materials and items
employed in the cleanup of releases. You will need todetermine which regulations are applicable.
Sections 13 and 15 of this SDS provide information regarding
certain local or national requirements.
SECTION 7. HANDLING AND STORAGE
Technical measures:

Local/Total ventilation
Advice on safe handling::

Conditions for safe storage:

Materials to avoid:

Static electricity may accumulate and ignite suspended dust
causing an explosion.
Provide adequate precautions, such as electrical grounding
and bonding, or inert atmospheres.
Use only with adequate ventilation.
Do not get on skin or clothing.
Do not breathe dust.
Do not swallow.
Avoid contact with eyes.
Wash skin thoroughly after handling.
Handle in accordance with good industrial hygiene and safety
practice, based on the results of the workplace exposure
assessment
Minimize dust generation and accumulation.
Keep container closed when not in use.
Keep away from heat and sources of ignition.
Take precautionary measures against static discharges.
Do not eat, drink or smoke when using this product.
Take care to prevent spills, waste and minimize release to theenvironment.
Keep in properly labeled containers.
Store in accordance with the particular national regulations.
Do not store with the following product types:
Strong oxidizing agents
Self-reactive substances and mixtures
Organic peroxides
Explosives
Gases

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Ingredients with workplace control parameters
inert or nuisance dust
50 Million particles per cubic footValue type (Form of exposure): TWA (total dust)
Basis: OSHA Z-3
15 mg/m³
Value type (Form of exposure): TWA (total dust)
Basis: OSHA Z-3
4 / 20SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

5 mg/m³
Value type (Form of exposure): TWA (respirable fraction)
Basis: OSHA Z-3
15 Million particles per cubic footValue type (Form of exposure): TWA (respirable fraction)
Basis: OSHA Z-3
Dust, nuisance dust and particulates

10 mg/m³
Value type (Form of exposure): PEL (Total dust)
Basis: CAL PEL
5 mg/m³
Value type (Form of exposure): PEL (respirable dust fraction)
Basis: CAL PEL

Components

CAS-No.

Cellulose

9004-34-6

Peppermint oil

8006-90-4

Starch

9005-25-8

Rizatriptan

Engineering measures

145202-66-0:

Value type
(Form ofexposure)
TWA
TWA (Respirable)
TWA (total)
TWA (total
dust)
TWA (respirable fraction)
TWA (mist total)
TWA (mist respirable)
TWA
TWA (Respirable)
TWA (total)
TWA (total
dust)
TWA (respirable fraction)
TWA
Wipe limit

Control parameters / Permissible
concentration
10 mg/m³
5 mg/m³

Basis

10 mg/m³
15 mg/m³

NIOSH REL
OSHA Z-1

5 mg/m³

OSHA Z-1

10 mg/m³

NIOSH REL

5 mg/m³

NIOSH REL

10 mg/m³
5 mg/m³

ACGIH
NIOSH REL

10 mg/m³
15 mg/m³

NIOSH REL
OSHA Z-1

5 mg/m³

OSHA Z-1

10 µg/m3 (OEB 3)
100 µg/100 cm²Internal
Internal

ACGIH
NIOSH RELAll engineering controls should be implemented by facility
design and operated in accordance with GMP principles toprotect products, workers, and the environment.
Containment technologies suitable for controlling compounds
are required to control at source and to prevent migration of
the compound to uncontrolled areas (e.g., open-facecontainment devices).
Minimize open handling.

Personal protective equipment
5 / 20SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

Respiratory protection

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016:

General and local exhaust ventilation is recommended tomaintain vapor exposures below recommended limits. Where
concentrations are above recommended limits or are
unknown, appropriate respiratory protection should be worn.
Follow OSHA respirator regulations (29 CFR 1910.134) anduse NIOSH/MSHA approved respirators. Protection provided
by air purifying respirators against exposure to any
hazardous chemical is limited. Use a positive pressure air
supplied respirator if there is any potential for uncontrolled
release, exposure levels are unknown, or any othercircumstance where air purifying respirators may not provide
adequate protection.

Material:

Chemical-resistant gloves

Remarks
Eye protection::

Skin and body protection:

Hygiene measures:

Consider double gloving.
Wear safety glasses with side shields or goggles.
If the work environment or activity involves dusty conditions,mists or aerosols, wear the appropriate goggles.
Wear a faceshield or other full face protection if there is apotential for direct contact to the face with dusts, mists, oraerosols.
Work uniform or laboratory coat.
Additional body garments should be used based upon thetask being performed (e.g., sleevelets, apron, gauntlets,
disposable suits) to avoid exposed skin surfaces.
Use appropriate degowning techniques to remove potentiallycontaminated clothing.
If exposure to chemical is likely during typical use, provide
eye flushing systems and safety showers close to theworking place.
When using do not eat, drink or smoke.
Contaminated work clothing should not be allowed out of theworkplace.
Wash contaminated clothing before re-use.
The effective operation of a facility should include review ofengineering controls, proper personal protective equipment,
appropriate degowning and decontamination procedures,industrial hygiene monitoring, medical surveillance and theuse of administrative controls.

Hand protection

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance:

powderColor:

No data available

Odor

:

No data available

Odor Threshold:

No data available

pH:

No data available

6 / 20SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

Melting point/freezing point:

No data available

Initial boiling point and boiling
range

:

No data available

Flash point:

Not applicable

Evaporation rate:

No data available

Flammability (solid, gas):

May form explosive dust-air mixture during processing,handling or other means.

Flammability (liquids):

No data available

Upper explosion limit / Upper
flammability limit:

No data available

Lower explosion limit / Lower
flammability limit:

No data available

Vapor pressure:

No data available

Relative vapor density:

No data available

Relative density:

No data available

Density:

No data available

Solubility(ies)
Water solubility:

No data available

Partition coefficient: noctanol/water
Autoignition temperature:

No data available:

No data available

Decomposition temperature:

No data available

Viscosity
Viscosity, kinematic:

No data available

Explosive properties:

Not explosive

Oxidizing properties:

The substance or mixture is not classified as oxidizing.

Molecular weight:

No data available

Particle characteristics
Particle size:

No data available

SECTION 10. STABILITY AND REACTIVITY

7 / 20SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

Reactivity
Chemical stability
Possibility of hazardous reactions:::

Not classified as a reactivity hazard.
Stable under normal conditions.
May form explosive dust-air mixture during processing,handling or other means.
Can react with strong oxidizing agents.

Conditions to avoid:

Incompatible materials
Hazardous decomposition
products::

Heat, flames and sparks.
Avoid dust formation.
Oxidizing agents
No hazardous decomposition products are known.

SECTION 11. TOXICOLOGICAL INFORMATION
Information on likely routes of exposure
Inhalation
Skin contact
Ingestion
Eye contact
Acute toxicity
Not classified based on available information.
Product:
Acute oral toxicity:

Acute toxicity estimate: > 5,000 mg/kg
Method: Calculation method

Cellulose:
Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Acute inhalation toxicity:

LC50 (Rat): > 5.8 mg/l
Exposure time: 4 h
Test atmosphere: dust/mist

Acute dermal toxicity:

LD50 (Rabbit): > 2,000 mg/kg

Aspartame:
Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Peppermint oil:
Acute oral toxicity:

LD50 (Rat): > 2,000 mg/kg

Acute dermal toxicity:

LD50 (Rabbit): > 5,000 mg/kg

Starch:Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Acute dermal toxicity:

LD50 (Rabbit): > 2,000 mg/kg

Components:

8 / 20SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

Rizatriptan:
Acute oral toxicity

SDS Number:
809075-00016:

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

LD50 (Rat): 2,227 mg/kg
LD50 (Mouse): 700 - 1,631 mg/kg

Skin corrosion/irritation
Not classified based on available information.
Components:
Peppermint oil:SpeciesResultRemarks:::

RabbitSkin irritation
Based on data from similar materials

Rizatriptan:
SpeciesResult::RabbitNo skin irritation

Serious eye damage/eye irritation
Not classified based on available information.
Components:
Peppermint oil:SpeciesResultRemarks:::

RabbitIrritation to eyes, reversing within 21 days
Based on data from similar materials

Starch:SpeciesResult::RabbitNo eye irritation

Rizatriptan:
Species
Remarks::

Bovine cornea
Moderate eye irritation

Respiratory or skin sensitization
Skin sensitization
May cause an allergic skin reaction.
Respiratory sensitization
Not classified based on available information.
Components:
Peppermint oil:
Test Type
Routes of exposure
Species:::

Local lymph node assay (LLNA)
Skin contact
Mouse
9 / 20SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

MethodResultRemarks:::

OECD Test Guideline 429
positive
Based on data from similar materials

Assessment:

Probability or evidence of skin sensitization in humans

Starch:Test Type
Routes of exposure
SpeciesResult::::Maximization Test
Skin contact
Guinea pig
negative

Rizatriptan:
Test Type
Routes of exposure
Species
Assessment
Result:::::Maximization Test
DermalGuinea pig
Does not cause skin sensitization.
negative

Germ cell mutagenicity
Not classified based on available information.
Components:
Cellulose:
Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative
Test Type: In vitro mammalian cell gene mutation test
Result: negative

Genotoxicity in vivo:

Test Type: Mammalian erythrocyte micronucleus test (in vivo
cytogenetic assay)
Species: Mouse
Application Route: Ingestion
Result: negative

Aspartame:
Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative
Test Type: DNA damage and repair, unscheduled DNA synthesis in mammalian cells (in vitro)
Result: negative

Genotoxicity in vivo:

Test Type: Mutagenicity (in vivo mammalian bone-marrowcytogenetic test, chromosomal analysis)
Species: Rat
Application Route: Ingestion
Result: negative

10 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

Starch:Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative

Rizatriptan:
Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative
Test Type: Alkaline elution assay
Result: negative
Test Type: In vitro mammalian cell gene mutation test
Result: negative
Test Type: Chromosome aberration test in vitro
Result: negative

Genotoxicity in vivo:

Test Type: Mammalian erythrocyte micronucleus test (in vivo
cytogenetic assay)
Species: Mouse
Application Route: Oral
Result: negative

Carcinogenicity
Not classified based on available information.
Components:
Cellulose:
Species
Application RouteExposure time
Result

:
:
:
:

Rat
Ingestion
72 weeks
negative

Aspartame:Species
Application RouteExposure time
Result

:
:
:
:

Rat
Ingestion
104 weeks
negative

Rizatriptan:
Species
Application RouteExposure time
NOAEL
Result

:
:
:
:
:

Mouse
Oral
100 weeks
125 mg/kg body weight
negative

Species
Application RouteExposure time
NOAEL

:
:
:
:

Rat
Oral
106 weeks
106 mg/kg body weight
11 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

ResultIARC

SDS Number:
809075-00016:

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

negative

Group 2B: Possibly carcinogenic to humans
Aspartame

22839-47-0

OSHA

No component of this product present at levels greater than or equal to 0.1% is
on OSHA’s list of regulated carcinogens.

NTP

No ingredient of this product present at levels greater than or equal to 0.1% isidentified as a known or anticipated carcinogen by NTP.

Reproductive toxicity
Suspected of damaging the unborn child.
Components:
Cellulose:
Effects on fertility:

Test Type: One-generation reproduction toxicity study
Species: Rat
Application Route: Ingestion
Result: negative

Effects on fetal development:

Test Type: Fertility/early embryonic development
Species: Rat
Application Route: Ingestion
Result: negative

Aspartame:
Effects on fertility:

Test Type: Two-generation reproduction toxicity study
Species: Rat
Application Route: Ingestion
Result: negative

Effects on fetal development:

Test Type: Embryo-fetal development
Species: Rat
Application Route: Ingestion
Result: negative

Rizatriptan:
Effects on fertility:

Test Type: Fertility/early embryonic development
Species: Rat, female
Application Route: Oral
Fertility: LOAEL: 100 mg/kg body weight
Symptoms: altered estrus cycles
Result: No effects on fertility and early embryonicdevelopment were detected.
Test Type: Fertility/early embryonic development
Species: Rat, male
Application Route: Oral
Fertility: NOAEL: 250 mg/kg body weight
Result: No effects on fertility and early embryonic
12 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

development were detected.
Effects on fetal development:

Test Type: Embryo-fetal development
Species: Rat
Application Route: Oral
Developmental Toxicity: LOAEL: 10 mg/kg body weight
Result: No teratogenic effects., Embryo-fetal toxicity.
Test Type: Embryo-fetal development
Species: Rabbit
Application Route: Oral
Developmental Toxicity: LOAEL: 100 mg/kg body weight
Result: No teratogenic effects., Embryo-fetal toxicity.
Remarks: The effects were seen only at maternally toxic doses.

Reproductive toxicity - Assessment:

Some evidence of adverse effects on development, based onanimal experiments.

STOT-single exposure
Not classified based on available information.
Components:
Rizatriptan:
Assessment:

May cause drowsiness or dizziness.

STOT-repeated exposure
Causes damage to organs (Cardio-vascular system) through prolonged or repeated exposure if
swallowed.
Components:
Rizatriptan:
Target Organs
Assessment::

Cardio-vascular system
Causes damage to organs through prolonged or repeatedexposure.

Cellulose:
Species
NOAEL
Application RouteExposure time

:
:
:
:

Rat
>= 9,000 mg/kg
Ingestion
90 Days

Aspartame:Species
NOAEL
Application Route

:
:
:

Rat
>= 4,000 mg/kg
Ingestion

Repeated dose toxicity
Components:

13 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

Exposure time:

104 Weeks

Starch:Species
NOAEL
Application RouteExposure time
Method

:
:
:
:
:

Rat
>= 2,000 mg/kg
Skin contact
28 Days
OECD Test Guideline 410

Rizatriptan:
Species
LOAEL
Application RouteExposure time
Symptoms

:
:
:
:
:

Rat
1 mg/kgOral
14 Weeks
Dilatation of the pupil, Increased pulse rate, Redness

Species
LOAEL
Application RouteExposure time
Symptoms

:
:
:
:
:

Dog
0.05 mg/kg
Intravenous
2 Weeks
Dilatation of the pupil, Increased pulse rate, Redness

Species
LOAEL
Application RouteExposure time
Symptoms

:
:
:
:
:

Dog
0.2 mg/kg
Oral
1y
Dilatation of the pupil

Aspiration toxicity
Not classified based on available information.
Experience with human exposure
Components:
Rizatriptan:
Ingestion:

Target Organs: Cardio-vascular system
Symptoms: asthenia, Fatigue, Pain, Dizziness, Weakness,
Drowsiness

SECTION 12. ECOLOGICAL INFORMATION
Ecotoxicity
Components:
Cellulose:
Toxicity to fish:

LC50 (Oryzias latipes (Japanese medaka)): > 100 mg/l
Exposure time: 48 h
Remarks: Based on data from similar materials

Aspartame:
14 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

Toxicity to fish:

LC50 (Danio rerio (zebra fish)): > 20 g/l
Exposure time: 96 h

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Daphnia magna (Water flea)): > 100 mg/l
Exposure time: 48 h
Method: OECD Test Guideline 202

Toxicity to algae/aquaticplants:

ErC50 (Desmodesmus subspicatus (green algae)): > 100 mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201:

LL50 (Danio rerio (zebra fish)): > 10 - 100 mg/l
Exposure time: 96 h
Remarks: Based on data from similar materials

Toxicity to daphnia and otheraquatic invertebrates:

EL50 (Daphnia magna (Water flea)): > 10 - 100 mg/l
Exposure time: 48 h
Remarks: Based on data from similar materials

Toxicity to algae/aquaticplants:EL50 (Desmodesmus subspicatus (green algae)): > 10 - 100
mg/l
Exposure time: 72 h
Remarks: Based on data from similar materials

Toxicity to microorganisms:

EC10: 51 mg/l
Exposure time: 3 hRemarks: Based on data from similar materials

Rizatriptan:
Toxicity to fish:

LC50 (Pimephales promelas (fathead minnow)): > 1,000 mg/l
Exposure time: 96 h

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Daphnia magna (Water flea)): 1,000 mg/l
Exposure time: 48 h

Toxicity to algae/aquaticplants:

EC50 (Pseudokirchneriella subcapitata (green algae)): > 100
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201

Peppermint oil:
Toxicity to fish

NOEC (Pseudokirchneriella subcapitata (green algae)): 48
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201
Toxicity to fish (Chronic toxicity):

Toxicity to daphnia and other :aquatic invertebrates (Chron-

NOEC (Pimephales promelas (fathead minnow)): 9.6 mg/l
Exposure time: 32 d
Method: OECD Test Guideline 210
NOEC (Daphnia magna (Water flea)): 110 mg/l
Exposure time: 21 d
15 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

ic toxicity)
Toxicity to microorganisms

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

Method: OECD Test Guideline 211:

EC50: > 1,000 mg/l
Exposure time: 3 hTest Type: Respiration inhibition
Method: OECD Test Guideline 209
NOEC: 1,000 mg/l
Exposure time: 3 hTest Type: Respiration inhibition
Method: OECD Test Guideline 209

Persistence and degradability
Components:
Cellulose:
Biodegradability:

Result: Readily biodegradable.

Aspartame:
Biodegradability:

Result: Readily biodegradable.
Method: OECD Test Guideline 301F

Peppermint oil:
Biodegradability:

Result: Readily biodegradable.
Remarks: Based on data from similar materials

Rizatriptan:
Biodegradability:

Result: Not readily biodegradable.
Biodegradation: 50 %Exposure time: 13 d
Method: OECD Test Guideline 314

Aspartame:
Partition coefficient: noctanol/water:log Pow: 0.07
Remarks: Calculation

Peppermint oil:
Partition coefficient: noctanol/water:log Pow: > 4
Remarks: Based on data from similar materials

Rizatriptan:
Partition coefficient: noctanol/water:log Pow: -0.649

Bioaccumulative potential
Components:

16 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

Mobility in soil
Components:
Rizatriptan:
Distribution among environmental compartments:

log Koc: 3.83
Method: OECD Test Guideline 106

Other adverse effects
No data available
SECTION 13. DISPOSAL CONSIDERATIONS
Disposal methods
Waste from residues:

Contaminated packaging:

Dispose of in accordance with local regulations.
Do not dispose of waste into sewer.
Empty containers should be taken to an approved waste
handling site for recycling or disposal.
If not otherwise specified: Dispose of as unused product.

SECTION 14. TRANSPORT INFORMATIONInternational Regulations
UNRTDG
Not regulated as a dangerous good
IATA-DGR
Not regulated as a dangerous good
IMDG-CodeNot regulated as a dangerous goodTransport in bulk according to Annex II of MARPOL 73/78 and the IBC CodeNot applicable for product as supplied.
Domestic regulation
49 CFR
Not regulated as a dangerous goodSpecial precautions for user
Not applicable
SECTION 15. REGULATORY INFORMATIONCERCLA Reportable Quantity
This material does not contain any components with a CERCLA RQ.
SARA 304 Extremely Hazardous Substances Reportable Quantity
This material does not contain any components with a section 304 EHS RQ.
SARA 302 Extremely Hazardous Substances Threshold Planning Quantity
This material does not contain any components with a section 302 EHS TPQ.
17 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

SARA 311/312 Hazards:

Combustible dust
Respiratory or skin sensitization
Reproductive toxicity
Specific target organ toxicity (single or repeated exposure)

SARA 313:

This material does not contain any chemical components withknown CAS numbers that exceed the threshold (De Minimis)
reporting levels established by SARA Title III, Section 313.

US State Regulations
Pennsylvania Right To Know
Gelatins
D-mannitol
Cellulose
GlycineD-Glucose, 4-O-β-D-galactopyranosyl-, monohydrate
Aspartame
Peppermint oil
Starch9000-70-8
69-65-89004-34-6
56-40-664044-51-5
22839-47-0
8006-90-4
9005-25-8

California Prop. 65
WARNING: This product can expose you to chemicals including Quartz, which is/are known to
the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
California Permissible Exposure Limits for Chemical Contaminants
Cellulose
Peppermint oil
Starch

9004-34-6
8006-90-4
9005-25-8

The ingredients of this product are reported in the following inventories:
AICS: not determinedDSL:

not determined

IECSC

:

not determined

SECTION 16. OTHER INFORMATION
Further information

18 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

NFPA 704:

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016
HMIS® IV:

Flammability

HEALTH1
Health20Special hazard*

3

FLAMMABILITY

3

PHYSICAL HAZARD

0

Instability

HMIS® ratings are based on a 0-4 rating
scale, with 0 representing minimal hazards or risks, and 4 representing significant hazards or risks. The "*" represents
a chronic hazard, while the "/" represents
the absence of a chronic hazard.

Full text of other abbreviations
ACGIH: USA. ACGIH Threshold Limit Values (TLV)
CAL PEL: California permissible exposure limits for chemical contaminants (Title 8, Article 107)
NIOSH REL
: USA. NIOSH Recommended Exposure Limits
OSHA Z-1: USA. Occupational Exposure Limits (OSHA) - Table Z-1 Limits for Air Contaminants
OSHA Z-3: USA. Occupational Exposure Limits (OSHA) - Table Z-3 Mineral Dusts
ACGIH / TWA: 8-hour, time-weighted average
CAL PEL / PEL: Permissible exposure limit
NIOSH REL / TWA: Time-weighted average concentration for up to a 10-hour
workday during a 40-hour workweek
OSHA Z-1 / TWA: 8-hour time weighted average
OSHA Z-3 / TWA: 8-hour time weighted average
AIIC - Australian Inventory of Industrial Chemicals; ASTM - American Society for the Testing ofMaterials; bw - Body weight; CERCLA - Comprehensive Environmental Response, Compensation,and Liability Act; CMR - Carcinogen, Mutagen or Reproductive Toxicant; DIN - Standard of theGerman Institute for Standardisation; DOT - Department of Transportation; DSL - Domestic Substances List (Canada); ECx - Concentration associated with x% response; EHS - Extremely Hazardous Substance; ELx - Loading rate associated with x% response; EmS - Emergency Schedule;
ENCS - Existing and New Chemical Substances (Japan); ErCx - Concentration associated with
x% growth rate response; ERG - Emergency Response Guide; GHS - Globally Harmonized System; GLP - Good Laboratory Practice; HMIS - Hazardous Materials Identification System; IARC International Agency for Research on Cancer; IATA - International Air Transport Association; IBC- International Code for the Construction and Equipment of Ships carrying Dangerous Chemicals
in Bulk; IC50 - Half maximal inhibitory concentration; ICAO - International Civil Aviation Organization; IECSC - Inventory of Existing Chemical Substances in China; IMDG - International Maritime
Dangerous Goods; IMO - International Maritime Organization; ISHL - Industrial Safety and Health
Law (Japan); ISO - International Organisation for Standardization; KECI - Korea Existing Chemicals Inventory; LC50 - Lethal Concentration to 50 % of a test population; LD50 - Lethal Dose to
50% of a test population (Median Lethal Dose); MARPOL - International Convention for the Pre19 / 20

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Rizatriptan Orally Disintegrating Formulation
Version
7.0

Revision Date:
04/06/2024

SDS Number:
809075-00016

Date of last issue: 09/30/2023
Date of first issue: 07/22/2016

vention of Pollution from Ships; MSHA - Mine Safety and Health Administration; n.o.s. - Not Otherwise Specified; NFPA - National Fire Protection Association; NO(A)EC - No Observed (Adverse)
Effect Concentration; NO(A)EL - No Observed (Adverse) Effect Level; NOELR - No Observable
Effect Loading Rate; NTP - National Toxicology Program; NZIoC - New Zealand Inventory ofChemicals; OECD - Organization for Economic Co-operation and Development; OPPTS - Officeof Chemical Safety and Pollution Prevention; PBT - Persistent, Bioaccumulative and Toxic substance; PICCS - Philippines Inventory of Chemicals and Chemical Substances; (Q)SAR - (Quantitative) Structure Activity Relationship; RCRA - Resource Conservation and Recovery Act;REACH - Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals; RQ - Reportable
Quantity; SADT - Self-Accelerating Decomposition Temperature; SARA - Superfund Amendments and Reauthorization Act; SDS - Safety Data Sheet; TCSI - Taiwan Chemical SubstanceInventory; TECI - Thailand Existing Chemicals Inventory; TSCA - Toxic Substances Control Act(United States); UN - United Nations; UNRTDG - United Nations Recommendations on theTransport of Dangerous Goods; vPvB - Very Persistent and Very Bioaccumulative

Sources of key data used tocompile the Material Safety
Data Sheet:Internal technical data, data from raw material SDSs, OECD
eChem Portal search results and European Chemicals Agency, http://echa.europa.eu/

Revision Date:

04/06/2024

Items where changes have been made to the previous version are highlighted in the body of thisdocument by two vertical lines.
The information provided in this Safety Data Sheet is correct to the best of our knowledge,
information and belief at the date of its publication. The information is designed only as a
guidance for safe handling, use, processing, storage, transportation, disposal and release andshall not be considered a warranty or quality specification of any type. The information provided
relates only to the specific material identified at the top of this SDS and may not be valid when the
SDS material is used in combination with any other materials or in any process, unless specified
in the text. Material users should review the information and recommendations in the specificcontext of their intended manner of handling, use, processing and storage, including anassessment of the appropriateness of the SDS material in the user’s end product, if applicable.
US / Z8

20 / 20